Welcome Guest | Register / Login

Global Breast Cancer Market Report: 2014 Edition

Table of Contents

1. Market Overview
1.1 Breast Cancer
1.2 Types of Breast Cancer
1.3 Risk Factors
1.4 Symptoms of Breast Cancer
1.5 Diagnosis and Treatment of Breast Cancer
1.5.1 Breast Cancer Screening and Diagnostic Measures
1.5.2 Breast Cancer Treatment

2. Breast Cancer Market
2.1 Global Market
Market Value
Market Segments
2.2 Breast Cancer Diagnostics Market
2.2.1 The US
2.2.2 Brazil
2.2.3 India
2.2.4 China
2.3 Breast Cancer Therapeutics Market
2.3.1 Regional Analysis
2.3.2 Metastatic Breast Cancer
The US

3. Market Dynamics
3.1 Industry Developments
3.1.1 Diagnostic Tests
3.1.2 New Drugs & Therapies
3.2 Growth Drivers
3.2.1 Increasing Prevalence of Cancer Cases
3.2.2 Increasing Use of Tobacco and Alcohol
3.2.3 Expanding Obese and Diabetes Population
3.2.4 Rising Demand for Better Healthcare Options
3.2.5 Growing Women Population (+45 Years)
3.2.6 Increased Spending on Medicines
3.2.7 Dense Breast Tissue
3.2.8 Race\Ethnicity
3.2.9 Exposure to Oestrogen
3.2.10 Hormonal Factors or HRT (Hormone Replacement Therapy)
3.2.11 Exposure to Radiation
3.3 Challenges
3.3.1 Rising Costs of Treatment
3.3.2 Stringent Regulatory Measures
3.3.3 Adverse Effects of the Treatment
3.3.4 Mounting Price Pressure

4. Competitive Landscape
Competitive Overview
Market Share

5. Company Profiles
5.1 Hologic, Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Focus on Research & Development
Business Expansion via Acquisitions
5.2 Johnson & Johnson
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Research and Development Activities
Strategic Acquisitions
5.3 F. Hoffmann-La Roche Ltd
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Accelerating R&D Activities
Building on Strength in Biotechnology
5.4 Novartis
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
Focus on R&D Activities
Business Expansion via Acquisitions
5.5 Siemens AG
5.5.1 Business Overview
5.5.2 Financial Overview
5.5.3 Business Strategies
Optimum Allocation of R&D Resources
Focus on Healthcare Segment

List of Tables

Stages of Breast Cancer
New Cases of Breast Cancer and Estimated Deaths in the US (2014E)
The US Tomosynthesis Market Opportunity
NeuVax / E75 (nelipepimut) Estimated Sales – Breast Cancer Market Size Model (2017E-2020E)
The US MBC Market (in US$ Million) 2010-2015E
European MBC Market (in US$ Million) 2010-2015E
Metasite Breast and Menacalc Are Mechanistically Different From Existing Gene-Based Tests
Breast Cancer Drugs & Agents in Clinical Development
Number of Cancer Cases Worldwide (2012)
IARC and WCRF/AICR Evaluations of Breast Cancer Risk Factors
FDA Regulation of Medical Devices
Comparison of Adjuvant Chemotherapy Tests in Breast Cancer
J&J’s R&D Statistics (2012 & 2013)

List of Charts

Types of Breast Cancer
Various Biopsy Methods
Global Oncology Spending (2010-2014E)
Global Breast Cancer Market by Segments (2013E)
Global Breast Cancer Predictive Diagnostic and Drug Technologies (2010-2014E)
The US Breast Imaging Systems Market (2010-2014E)
The US Digital Mammography Market (2010-2013)
Brazil’s Breast Cancer Imaging Market (2010-2014E)
India’s Breast Screening Market (2010-2014E)
China’s Breast Screening Market (2010-2014E)
Global Breast Cancer Therapeutics Market (2010-2014E)
Breast Cancer Therapeutics Market by Region
The US Metastatic Breast Cancer Market Revenues (2010-2014E)
Chinese Metastatic Breast Cancer Market Revenues (2010-2014E)
Breast Cancer Drug Breakdown in China (2013E)
Different Types of Cancer Worldwide (2012)
Increasing Prevalence of Diabetes by Region (2000-2030E)
Global Female Population, +45 Years (2008-2014E)
Global Spending on Medicines (2007-2017E)
New Female Breast Cancer Cases and Deaths by Age, US, (2013)
Global Oncology Pharmaceuticals - Market Share (2013E)
Global Breast Cancer Diagnostics – Market Share (2013E)
Hologic’s Revenue Share by Business Segment (2013)
Hologic’s Revenues (2009-2013)
Johnson & Johnson’s Revenues (2009-2013)
F. Hoffmann-La Roche - Business Segments (2013)
Roche Revenues (2009-2013)
Novartis Business Segments (2013)
Novartis Revenues (2009-2013)
Siemens AG’s Revenue by Business Segments (2013)
Siemens AG’s Revenues & Net Income (2009-2012)

Why http://www.marketreportsonline.com/
Published By :Koncept Analytics